CHARLES SCHWAB INVESTMENT MANAGEMENT INC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 47 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$24,487
+158.7%
31,5350.0%0.00%
Q4 2022$9,464
-40.8%
31,5350.0%0.00%
Q3 2022$16,000
-15.8%
31,5350.0%0.00%
Q2 2022$19,000
-53.7%
31,5350.0%0.00%
Q1 2022$41,000
+13.9%
31,5350.0%0.00%
Q4 2021$36,000
-26.5%
31,5350.0%0.00%
Q3 2021$49,000
-22.2%
31,5350.0%0.00%
Q2 2021$63,000
+6.8%
31,5350.0%0.00%
Q1 2021$59,00031,5350.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders